Keros Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $168k | 2.9k | 58.07 |
| 2024-06-30 | $132k | 2.9k | 45.70 |
| 2024-03-31 | $170k | 2.6k | 66.20 |
| 2023-12-31 | $89k | 2.2k | 39.76 |
| 2023-09-30 | $71k | 2.2k | 31.88 |
| 2023-06-30 | $75k | 1.9k | 40.18 |
| 2023-03-31 | $60k | 1.4k | 42.70 |
| 2022-12-31 | $73k | 1.4k | 51.35 |
| 2022-09-30 | $53k | 1.4k | 37.56 |
| 2022-06-30 | $30k | 1.1k | 27.47 |
| 2022-03-31 | $59k | 1.1k | 54.03 |
| 2021-12-31 | $64k | 1.1k | 58.61 |
| 2021-09-30 | $43k | 1.1k | 39.38 |
| 2021-06-30 | $46k | 1.1k | 42.12 |
| 2021-03-31 | $67k | 1.1k | 61.36 |
| 2020-12-31 | $77k | 1.1k | 70.51 |
| 2020-09-30 | $24k | 615 | 39.02 |
| 2020-06-30 | $23k | 615 | 37.40 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors